Mr. David Brett reports

INOVENT CAPITAL AND JETLINES EXECUTE DEFINITIVE AGREEMENT ON PROPOSED QUALIFYING TRANSACTION

Inovent Capital Inc. and Canada Jetlines Ltd. have signed a definitive amalgamation agreement whereby the parties have agreed to amalgamate to form an amalgamated corporation (Amalco) under the terms set out below. Under the terms of the agreement, each shareholder of Inovent will receive one share of Amalco for every three shares of Inovent held. Each shareholder of Jetlines will receive 1.15 Amalco shares for each share of Jetlines held. Shareholders of Jetlines and Inovent will own approximately 81.5 per cent and 18.5 per cent of the outstanding Amalco shares, respectively. The transaction, if completed, will constitute Inovent's qualifying transaction in accordance with the policies of the TSX Venture Exchange.

The directors and officers of Inovent, as well as certain significant shareholders of Jetlines collectively holding approximately 42 per cent of the outstanding shares of Inovent and approximately 25.8 per cent of the outstanding shares of Jetlines, have entered into voting agreements, under which they agree to vote in favour of the transaction. The voting agreements terminate automatically upon termination of the agreement.

Transaction details

The transaction will take place by way of an amalgamation. Pursuant to the terms of the agreement, the completion of the transaction is conditional upon a number of items including, without limitation: approval of the shareholders of Inovent of the continuation of Inovent from the jurisdiction of British Columbia to the federal jurisdiction of Canada; approval of the shareholders of each of Inovent and Jetlines in respect of the transaction; completion of a financing of not less than $10-million; conditional approval of the TSX-V; and receipt of all other necessary regulatory approvals.

Holders of Inovent options and warrants, as well as holders of Jetlines options and warrants, will be entitled, on exercise, to receive common shares of Amalco, subject to an adjustment to reflect the completion of the transaction.

Upon completion of the transaction, the name of Amalco will be Canada Jetlines Ltd. The directors of Amalco are expected to be Jim Scott, Dixon Lawson, David Solloway, Sid Fattedad, Claude Morin and David Brett. The officers of Amalco are expected to be Mr. Scott, chief executive officer, Rick Low, chief financial officer, Mr. Lawson, chief administrative officer, Mr. Solloway, president and chief commercial officer, and Rick Lang, chief operating officer.

Full details of the transaction will be included in information circulars to be filed with securities regulatory authorities, and mailed to Inovent shareholders in connection with a special meeting of Inovent shareholders and to Jetlines shareholders in connection with a special meeting of Jetlines shareholders. Inovent and Jetlines shareholders are urged to read the respective information circulars once they become available, as they will contain additional important information about the transaction.

The transaction is expected to be completed in November, 2014, or such later date as the parties may agree. Inovent is a TSX-V capital pool company. Jetlines is a start-up airline aiming to become Canada's first ultralow-cost carrier.

Completion of the transaction is subject to a number of conditions, including but not limited to, TSX-V acceptance and if applicable pursuant to TSX-V requirements, majority of the minority shareholder approval. Where applicable, the transaction cannot close until the required shareholder approval is obtained. There can be no assurance that the transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared in connection with the transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

We seek Safe Harbor.